Skip to Main Content

Paper Details

Long-term safety of the tafenoquine antimalarial chemoprophylaxis regimen: A 12-month, randomized, double-blind, placebo-controlled trial.
Travel Med Infect Dis
6
2022
Author NameAffiliation
Fred K ChenCentre for Ophthalmology and Visual Sciences (incorporating Lions Eye Institute), The University of Western Australia, Australia Linear Clinical Research
  • 1 - 1

Datasets

Release 1.2